Emerging terbinafine-resistant Trichophyton indotineae between 2018 and 2023: a multinational genomic epidemiology study
The Lancet Microbe · 2026-02 · 7 (2) · 101273
DOI: 10.1016/j.lanmic.2025.101273 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Lancet Microbe, 2026-02. Verfasst von Johanna Rhodes und 17 weiteren Autor:innen. Beteiligte Einrichtung: Medical Research Council Centre for Global Infectious Disease Analysis, Imperial College London, London, UK; Department of Medical Microbiology, Radb…. Hauptthemen laut MEDLINE: Terbinafine, Antifungal Agents, Drug Resistance, Fungal, Trichophyton. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Medical Research Council, Science and Engineering Research Board, Canadian Institute for Advanced Research.
Abstract (Originalsprache)
BACKGROUND: Trichophyton species cause the greatest burden of dermatophytosis worldwide, with the Trichophyton mentagrophytes species complex being particularly associated with the emergence of new aggressive infections. One emerging species, Trichophyton indotineae is notable for its clinical resistance to terbinafine antifungal treatment and rapid global spread. In this study we aim to characterise the epidemiology of this emerging pathogen using genomics. METHODS: In this retrospective genomic epidemiology study, to better understand the epidemiology of this disease, we sourced isolates collected from patients with severe cases of dermatophytosis (identified either by internal transcribed spacer sequencing or phenotypic characterisation) in the UK, Ireland, France, Canada, and India for the period 2014-23, including the T indotineae type strain from Japan. We used whole-genome sequencing to confirm 90 isolates were T indotineae, and antifungal susceptibility testing to assess susceptibility to terbinafine. FINDINGS: 103 cases of severe dermatophytosis caused by Trichophyton species collected between 2018 and 2023 in the UK, France, Canada, Ireland, and India were included in this study. Susceptibility testing indicated that 63 (70%) of 90 T indotineae isolates were resistant to terbinafine (minimum inhibitory concentration [MIC] ≥0·5 mg/L). Pairwise genetic distances showed very high identity with only 147 (range 1-414) single-nucleotide polymorphisms (SNPs) separating isolates that were nested within a monophyletic phylogeny, supporting a single evolutionary origin of T indotineae. Genome-wide analyses identified multiple non-synonymous SNPs in SQLE (ERG1), the squalene epoxidase target of terbinafine, that were associated with terbinafine in vitro resistance of 0·5 mg/L or higher. However, six isolates exhibited high MIC values without SQLE mutations, suggesting the presence of alternative resistance mechanisms. INTERPRETATION: That no clear geographical clustering of isolates was observed confirms the rapid transcontinental spread of T indotineae from its likely centre of diversity in Asia. Our findings highlight the importance of better genomic surveillance to understand and manage this severe and rapidly emerging terbinafine-resistant dermatophyte. FUNDING: None.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Medical Research Council Centre for Global Infectious Disease Analysis, Imperial College London, London, UK; Department of Medical Microbiology, Radboudumc, Nijmegen, Netherlands. Electronic address: johanna.rhodes@impe…
- Medical Research Council Centre for Global Infectious Disease Analysis, Imperial College London, London, UK; Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, UK.
- Service de Parasitologie-Mycologie, Hôpital Saint-Louis, Assistance Publique - Hôpitaux de Paris, Paris, France; Institut Pasteur, Immunology of Fungal Infections, Université Paris-Cité, Paris, France.
- Sporometrics, Toronto, ON, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
- Medical Mycology Unit, Department of Microbiology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India; National Reference Laboratory for Antimicrobial Resistance in Fungal Pathogens, Vallabhbhai Patel…
- Mycology Reference Centre, Leeds Teaching Hospitals National Health Service Trust, Leeds, UK.
Förderung
- Medical Research Council
- Science and Engineering Research Board
- Canadian Institute for Advanced Research
- Wellcome Trust
Zitieren
APA
Rhodes, J., Hui, S. T., Dellière, S., Summerbell, R. C., Scott, J. A., Kaur, A., Barton, R. C., Leitao, R., Hemmings, S., Goiriz, R., Lambourne, J., Farrer, R. A., Schelenz, S., Hay, R. J., Borman, A. M., Chowdhary, A., Abdolrasouli, A., & Fisher, M. C. (2026). Emerging terbinafine-resistant Trichophyton indotineae between 2018 and 2023: a multinational genomic epidemiology study. The Lancet Microbe, 7(2), 101273. https://doi.org/10.1016/j.lanmic.2025.101273
Vancouver
Rhodes J, Hui ST, Dellière S, Summerbell RC, Scott JA, Kaur A, et al. Emerging terbinafine-resistant Trichophyton indotineae between 2018 and 2023: a multinational genomic epidemiology study. The Lancet Microbe. 2026;7(2):101273. doi:10.1016/j.lanmic.2025.101273
BibTeX
@article{Rhodes2026,
author = {Rhodes, Johanna and Hui, Sui Ting and Dellière, Sarah and Summerbell, Richard C and Scott, James A and Kaur, Amtoj and Barton, Richard C and Leitao, Rodrigo and Hemmings, Samuel and Goiriz, Rebeca and Lambourne, Jonathan and Farrer, Rhys A and Schelenz, Silke and Hay, Roderick J and Borman, Andrew M and Chowdhary, Anuradha and Abdolrasouli, Alireza and Fisher, Matthew C},
title = {Emerging terbinafine-resistant Trichophyton indotineae between 2018 and 2023: a multinational genomic epidemiology study},
journal = {The Lancet Microbe},
year = {2026},
volume = {7},
number = {2},
pages = {101273},
doi = {10.1016/j.lanmic.2025.101273}
}
EUVIMED